1022MO Predicting overall survival of patients with melanoma and NSCLC treated with immunotherapy using AI combining total tumor volume and tumor heterogeneity on CT-Scans
Résumé
Using total tumor volume and AI tumor heterogeneity from CT scans, it may be possible to predict the prognosis of oncology patients, identify those who could benefit from immunotherapy, and provide valuable guidance for treatment.